{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T17:37:48Z","timestamp":1787593068216,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s40266-025-01229-x","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T09:26:32Z","timestamp":1752139592000},"page":"781-789","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["One-Year Mortality in Hospitalized, Frail Older Adults with Atrial Fibrillation on Oral Anticoagulant Therapy: Impact of Stroke and Bleeding Events"],"prefix":"10.1007","volume":"42","author":[{"given":"Chukwuma","family":"Okoye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5284-9588","authenticated-orcid":false,"given":"Alberto","family":"Finazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Pagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Brunetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Presta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Monzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Bellelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Bo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,9]]},"reference":[{"issue":"40","key":"1229_CR1","doi-asserted-by":"publisher","first-page":"4194","DOI":"10.1093\/eurheartj\/ehab648","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N, et al. Corrigendum to: 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(40):4194. https:\/\/doi.org\/10.1093\/eurheartj\/ehab648.","journal-title":"Eur Heart J"},{"issue":"2","key":"1229_CR2","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1093\/ehjqcco\/qcab028","volume":"8","author":"KAA Fox","year":"2022","unstructured":"Fox KAA, Virdone S, Pieper KS, et al. GARFIELD-AF risk score for mortality, stroke, and bleeding within 2 years in patients with atrial fibrillation. Eur Heart J Qual Care Clin Outcomes. 2022;8(2):214\u201327. https:\/\/doi.org\/10.1093\/ehjqcco\/qcab028.","journal-title":"Eur Heart J Qual Care Clin Outcomes."},{"key":"1229_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2023.10.010","author":"M Bo","year":"2023","unstructured":"Bo M, Fumagalli S, Degli Esposti L, et al. Anticoagulation in atrial fibrillation. A large real-world update. Eur J Intern Med. 2023. https:\/\/doi.org\/10.1016\/j.ejim.2023.10.010. (Published online 23 October 2023:S0953-6205(23)00365-5).","journal-title":"Eur J Intern Med"},{"key":"1229_CR4","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.16010","author":"A De Vincentis","year":"2024","unstructured":"De Vincentis A, Soraci L, Arena E, et al. Appropriateness of direct oral anticoagulant prescribing in older subjects with atrial fibrillation discharged from acute medical wards. Br J Clin Pharmacol. 2024. https:\/\/doi.org\/10.1111\/bcp.16010. (Published online 6 February 2024).","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"1229_CR5","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.jacc.2021.10.037","volume":"79","author":"AS Volgman","year":"2022","unstructured":"Volgman AS, Nair G, Lyubarova R, et al. Management of atrial fibrillation in patients 75 years and older: JACC state-of-the-art review. J Am Coll Cardiol. 2022;79(2):166\u201379. https:\/\/doi.org\/10.1016\/j.jacc.2021.10.037.","journal-title":"J Am Coll Cardiol"},{"key":"1229_CR6","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ejim.2019.10.026","volume":"71","author":"M Bo","year":"2020","unstructured":"Bo M, Marchionni N. Practical use of direct oral anti coagulants (DOACs) in the older persons with atrial fibrillation. Eur J Intern Med. 2020;71:32\u20138. https:\/\/doi.org\/10.1016\/j.ejim.2019.10.026.","journal-title":"Eur J Intern Med"},{"key":"1229_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2022.101652","volume":"79","author":"M Proietti","year":"2022","unstructured":"Proietti M, Romiti GF, Raparelli V, et al. Frailty prevalence and impact on outcomes in patients with atrial fibrillation: a systematic review and meta-analysis of 1,187,000 patients. Ageing Res Rev. 2022;79: 101652. https:\/\/doi.org\/10.1016\/j.arr.2022.101652.","journal-title":"Ageing Res Rev"},{"issue":"10","key":"1229_CR8","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1093\/europace\/euab065","volume":"23","author":"J Steffel","year":"2021","unstructured":"Steffel J, Collins R, Antz M, et al. 2021 European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol. 2021;23(10):1612\u201376. https:\/\/doi.org\/10.1093\/europace\/euab065.","journal-title":"Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol."},{"key":"1229_CR9","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ejim.2021.01.020","volume":"86","author":"V Calsolaro","year":"2021","unstructured":"Calsolaro V, Okoye C, Antognoli R, Dell\u2019Agnello U, Calabrese AM, Monzani F. Long-term effectiveness and safety of anticoagulation therapy in oldest old, frail people with atrial fibrillation. Eur J Intern Med. 2021;86:91\u20137. https:\/\/doi.org\/10.1016\/j.ejim.2021.01.020.","journal-title":"Eur J Intern Med"},{"issue":"5","key":"1229_CR10","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.003432","volume":"5","author":"ET Kato","year":"2016","unstructured":"Kato ET, Giugliano RP, Ruff CT, et al. Efficacy and safety of edoxaban in elderly patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial. J Am Heart Assoc. 2016;5(5): e003432. https:\/\/doi.org\/10.1161\/JAHA.116.003432.","journal-title":"J Am Heart Assoc"},{"key":"1229_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2022.101761","volume":"82","author":"R Presta","year":"2022","unstructured":"Presta R, Brunetti E, Polidori MC, Bo M. Impact of frailty models on the prescription of oral anticoagulants and on the incidence of stroke, bleeding, and mortality in older patients with atrial fibrillation: a systematic review. Ageing Res Rev. 2022;82: 101761. https:\/\/doi.org\/10.1016\/j.arr.2022.101761.","journal-title":"Ageing Res Rev"},{"issue":"3","key":"1229_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpth.2023.100129","volume":"7","author":"S Nishimura","year":"2023","unstructured":"Nishimura S, Kumamaru H, Shoji S, et al. Frailty and subsequent adverse outcomes in older patients with atrial fibrillation treated with oral anticoagulants: the Shizuoka study. Res Pract Thromb Haemost. 2023;7(3): 100129. https:\/\/doi.org\/10.1016\/j.rpth.2023.100129.","journal-title":"Res Pract Thromb Haemost."},{"issue":"6","key":"1229_CR13","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1161\/CIRCULATIONAHA.118.035012","volume":"139","author":"JP Bassand","year":"2019","unstructured":"Bassand JP, Virdone S, Goldhaber SZ, et al. Early risks of death, stroke\/systemic embolism, and major bleeding in patients with newly diagnosed atrial fibrillation. Circulation. 2019;139(6):787\u201398. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.035012.","journal-title":"Circulation"},{"issue":"20","key":"1229_CR14","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1093\/eurheartj\/ehu463","volume":"36","author":"C Held","year":"2015","unstructured":"Held C, Hylek EM, Alexander JH, et al. Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial. Eur Heart J. 2015;36(20):1264\u201372. https:\/\/doi.org\/10.1093\/eurheartj\/ehu463.","journal-title":"Eur Heart J"},{"issue":"2","key":"1229_CR15","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1093\/ehjqcco\/qcaa082","volume":"7","author":"H Ogawa","year":"2021","unstructured":"Ogawa H, An Y, Ishigami K, et al. Long-term clinical outcomes after major bleeding in patients with atrial fibrillation: the Fushimi AF registry. Eur Heart J Qual Care Clin Outcomes. 2021;7(2):163\u201371. https:\/\/doi.org\/10.1093\/ehjqcco\/qcaa082.","journal-title":"Eur Heart J Qual Care Clin Outcomes."},{"issue":"6","key":"1229_CR16","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.jamda.2013.03.022","volume":"14","author":"JE Morley","year":"2013","unstructured":"Morley JE, Vellas B, van Kan GA, et al. Frailty consensus: a call to action. J Am Med Dir Assoc. 2013;14(6):392\u20137. https:\/\/doi.org\/10.1016\/j.jamda.2013.03.022.","journal-title":"J Am Med Dir Assoc"},{"issue":"1","key":"1229_CR17","doi-asserted-by":"publisher","first-page":"24","DOI":"10.23736\/S0031-0808.21.04506-7","volume":"64","author":"P Rebora","year":"2022","unstructured":"Rebora P, Foc\u00e0 E, Salvatori A, et al. The effect of frailty on in-hospital and medium-term mortality of patients with COronaVIrus disease-19: the FRACOVID study. Panminerva Med. 2022;64(1):24\u201330. https:\/\/doi.org\/10.23736\/S0031-0808.21.04506-7.","journal-title":"Panminerva Med"},{"issue":"4","key":"1229_CR18","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","volume":"61","author":"E von Elm","year":"2008","unstructured":"von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344\u20139. https:\/\/doi.org\/10.1016\/j.jclinepi.2007.11.008.","journal-title":"J Clin Epidemiol"},{"key":"1229_CR19","doi-asserted-by":"publisher","unstructured":"Developed with the special contribution of the European Heart Rhythm Association (EHRA), endorsed by the European Association for Cardio-Thoracic Surgery (EACTS), Authors\/Task Force Members, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010;31(19):2369\u2013429. https:\/\/doi.org\/10.1093\/eurheartj\/ehq278","DOI":"10.1093\/eurheartj\/ehq278"},{"issue":"5","key":"1229_CR20","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373\u201383. https:\/\/doi.org\/10.1016\/0021-9681(87)90171-8.","journal-title":"J Chronic Dis"},{"issue":"3","key":"1229_CR21","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1093\/geront\/9.3_Part_1.179","volume":"9","author":"MP Lawton","year":"1969","unstructured":"Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9(3):179\u201386.","journal-title":"Gerontologist"},{"issue":"10","key":"1229_CR22","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/j.1532-5415.1975.tb00927.x","volume":"23","author":"E Pfeiffer","year":"1975","unstructured":"Pfeiffer E. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Am Geriatr Soc. 1975;23(10):433\u201341. https:\/\/doi.org\/10.1111\/j.1532-5415.1975.tb00927.x.","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"1229_CR23","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1093\/geront\/10.1_part_1.20","volume":"10","author":"S Katz","year":"1970","unstructured":"Katz S, Downs TD, Cash HR, Grotz RC. Progress in development of the index of ADL. Gerontologist. 1970;10(1):20\u201330. https:\/\/doi.org\/10.1093\/geront\/10.1_part_1.20.","journal-title":"Gerontologist"},{"issue":"5","key":"1229_CR24","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1503\/cmaj.050051","volume":"173","author":"K Rockwood","year":"2005","unstructured":"Rockwood K, Song X, MacKnight C, et al. A global clinical measure of fitness and frailty in elderly people. CMAJ Can Med Assoc J J Assoc Medicale Can. 2005;173(5):489\u201395. https:\/\/doi.org\/10.1503\/cmaj.050051.","journal-title":"CMAJ Can Med Assoc J J Assoc Medicale Can."},{"issue":"4","key":"1229_CR25","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1093\/ageing\/afab006","volume":"50","author":"O Theou","year":"2021","unstructured":"Theou O, P\u00e9rez-Zepeda MU, van der Valk AM, Searle SD, Howlett SE, Rockwood K. A classification tree to assist with routine scoring of the Clinical Frailty Scale. Age Ageing. 2021;50(4):1406\u201311. https:\/\/doi.org\/10.1093\/ageing\/afab006.","journal-title":"Age Ageing"},{"key":"1229_CR26","unstructured":"Clinical Frailty Scale. Specialised Clinical Frailty Network. Accessed 7 June 2025. https:\/\/www.scfn.org.uk\/clinical-frailty-scale"},{"issue":"4","key":"1229_CR27","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/eurheartj\/eht483","volume":"35","author":"JP Piccini","year":"2014","unstructured":"Piccini JP, Hammill BG, Sinner MF, et al. Clinical course of atrial fibrillation in older adults: the importance of cardiovascular events beyond stroke. Eur Heart J. 2014;35(4):250\u20136. https:\/\/doi.org\/10.1093\/eurheartj\/eht483.","journal-title":"Eur Heart J"},{"issue":"6","key":"1229_CR28","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1161\/CIRCULATIONAHA.118.036248","volume":"139","author":"N van Rein","year":"2019","unstructured":"van Rein N, Heide-J\u00f8rgensen U, Lijfering WM, Dekkers OM, S\u00f8rensen HT, Cannegieter SC. Major bleeding rates in atrial fibrillation patients on single, dual, or triple antithrombotic therapy. Circulation. 2019;139(6):775\u201386. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.036248.","journal-title":"Circulation"},{"issue":"1","key":"1229_CR29","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","volume":"149","author":"JA Joglar","year":"2024","unstructured":"Joglar JA, Chung MK, Armbruster AL, et al. 2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines. Circulation. 2024;149(1):e1\u2013156. https:\/\/doi.org\/10.1161\/CIR.0000000000001193.","journal-title":"Circulation"},{"key":"1229_CR30","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ijcard.2019.01.071","volume":"281","author":"M Giustozzi","year":"2019","unstructured":"Giustozzi M, Vedovati MC, Verso M, et al. Patients aged 90 years or older with atrial fibrillation treated with oral anticoagulants: a multicentre observational study. Int J Cardiol. 2019;281:56\u201361. https:\/\/doi.org\/10.1016\/j.ijcard.2019.01.071.","journal-title":"Int J Cardiol"},{"issue":"4","key":"1229_CR31","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1161\/CIRCULATIONAHA.121.056355","volume":"145","author":"AP Carnicelli","year":"2022","unstructured":"Carnicelli AP, Hong H, Connolly SJ, et al. Direct oral anticoagulants versus warfarin in patients with atrial fibrillation: patient-level network meta-analyses of randomized clinical trials with interaction testing by age and sex. Circulation. 2022;145(4):242\u201355. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.056355.","journal-title":"Circulation"},{"key":"1229_CR32","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/B978-0-12-804766-8.00021-2","volume":"167","author":"A Sharrief","year":"2019","unstructured":"Sharrief A, Grotta JC. Stroke in the elderly. Handb Clin Neurol. 2019;167:393\u2013418. https:\/\/doi.org\/10.1016\/B978-0-12-804766-8.00021-2.","journal-title":"Handb Clin Neurol"},{"issue":"4","key":"1229_CR33","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1161\/01.str.0000012515.66889.24","volume":"33","author":"GJ Hankey","year":"2002","unstructured":"Hankey GJ, Jamrozik K, Broadhurst RJ, Forbes S, Anderson CS. Long-term disability after first-ever stroke and related prognostic factors in the Perth Community Stroke Study, 1989\u20131990. Stroke. 2002;33(4):1034\u201340. https:\/\/doi.org\/10.1161\/01.str.0000012515.66889.24.","journal-title":"Stroke"},{"issue":"20","key":"1229_CR34","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1016\/j.jacc.2014.02.549","volume":"63","author":"EM Hylek","year":"2014","unstructured":"Hylek EM, Held C, Alexander JH, et al. Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin: the ARISTOTLE Trial (apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation): predictors, characteristics, and clinical outcomes. J Am Coll Cardiol. 2014;63(20):2141\u20137. https:\/\/doi.org\/10.1016\/j.jacc.2014.02.549.","journal-title":"J Am Coll Cardiol"},{"issue":"47","key":"1229_CR35","doi-asserted-by":"publisher","first-page":"4899","DOI":"10.1093\/eurheartj\/ehac587","volume":"43","author":"PB Meyre","year":"2022","unstructured":"Meyre PB, Blum S, Hennings E, et al. Bleeding and ischaemic events after first bleed in anticoagulated atrial fibrillation patients: risk and timing. Eur Heart J. 2022;43(47):4899\u2013908. https:\/\/doi.org\/10.1093\/eurheartj\/ehac587.","journal-title":"Eur Heart J"},{"key":"1229_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcha.2021.100739","volume":"33","author":"W Wang","year":"2021","unstructured":"Wang W, Lessard D, Saczynski JS, et al. Prognostic value of geriatric conditions for death and bleeding in older patients with atrial fibrillation. Int J Cardiol Heart Vasc. 2021;33: 100739. https:\/\/doi.org\/10.1016\/j.ijcha.2021.100739.","journal-title":"Int J Cardiol Heart Vasc."},{"issue":"15","key":"1229_CR37","doi-asserted-by":"publisher","first-page":"3893","DOI":"10.1007\/s11606-022-07410-x","volume":"37","author":"W Wang","year":"2022","unstructured":"Wang W, Saczynski JS, Lessard D, et al. Presence of geriatric conditions is prognostic of major bleeding in older patients with atrial fibrillation: a cohort study. J Gen Intern Med. 2022;37(15):3893\u20139. https:\/\/doi.org\/10.1007\/s11606-022-07410-x.","journal-title":"J Gen Intern Med"},{"key":"1229_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.archger.2016.12.001","volume":"70","author":"S Kim","year":"2017","unstructured":"Kim S, Yoon S, Choi J, et al. Clinical implication of frailty assessment in older patients with atrial fibrillation. Arch Gerontol Geriatr. 2017;70:1\u20137. https:\/\/doi.org\/10.1016\/j.archger.2016.12.001.","journal-title":"Arch Gerontol Geriatr"}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-025-01229-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-025-01229-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-025-01229-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T02:18:11Z","timestamp":1757211491000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-025-01229-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,9]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["1229"],"URL":"https:\/\/doi.org\/10.1007\/s40266-025-01229-x","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,9]]},"assertion":[{"value":"22 June 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research did not receive any funding from agencies in the public, commercial, or not-for-profit sectors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Chukwuma Okoye, Alberto Finazzi, Eleonora Pagan, Enrico Brunetti, Roberto Presta, Fabio Monzani, Giuseppe Bellelli, and Mario Bo declare no conflicts of interest that might be relevant to this work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"The study was approved by the relevant ethics committees (Tuscany Regional Ethics Committee for Clinical Experimentation: no. 23956)","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Participation"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The datasets supporting the results and analysis of this study are not publicly available but can be provided by the authors upon reasonable request and with justification.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Availability Statement"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"C.O., A.F., and E.P. contributed to the concept and design. E.B. and R.P. helped in acquisition of data. E.P. analyzed the data. C.O., A.F., E.P., F.M., and M.B. interpreted the data. C.O. and A.F. drafted the manuscript. F.M., G.B., M.B., and C.A. reviewed it critically for important intellectual content.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}